ADmit Therapeutics is a biotechnology company that specializes in the development of early Alzheimer's disease diagnosis tests. The company's test is based on an epigenetic analysis in blood samples, covering the analysis of a large number of methylcytosines in mtDNA by next-generation sequencing, enabling medical practitioners with aneasy way to detect early-stage Alzheimer.

Biotechnology

Health Care

Health Diagnostics

Pharmaceutical

ADmit Therapeutics

ADmit Therapeutics' headquarters in Barcelona, Spain

Description

People (4)

Jobs (0)

Other offices